ConductScience.org, home

Paper42049986

Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease.

Alasbali R and 17 others. Bone Marrow Transplant, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease. Papers, record 42049986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42049986

Download JSON
Disease
sickle cell disease163 drugs
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Excellent outcomes using a novel reduced intensity conditioning with thiotepa and post-transplant cyclophosphamide for HLA-matched related donor transplant in adolescents and adults with sickle cell disease.
PubMed
Journal
Bone Marrow Transplant
PubMed
Year
2026
PubMed
Publication types
Journal Article, Multicenter Study, Clinical Trial
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-11-05
PubMed

Authors18

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Alasbali RReem
2Alzahrani MMohsen
3Wilkerson KKarina
4Akhom PPhavina
5Alotaibi FFahad
6Alahmari BBaderhttps://orcid.org/0000-0002-6026-1347
7de la Fuente JJosuhttps://orcid.org/0000-0002-0974-1249
8DeBaun MRMichael R
9Rasheed WWalid
10Samarkandi HHadeel
11El Fakih RRiad
12Saleh MMostafahttps://orcid.org/0000-0001-8123-8405
13Elhassan TTusneem
14Alzahrani HHazza
15Aljurf MMahmoudhttps://orcid.org/0000-0003-3942-7370
16Almohareb FFahad
17Kassim AAAdetola Ahttps://orcid.org/0000-0002-0484-5903
18AlAhmari AAlihttps://orcid.org/0000-0002-7577-0152

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Anemia, Sickle CellMajor topic
Transplantation ConditioningMajor topic
CyclophosphamideMajor topic
ThiotepaMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Humans
Adolescent
Female
Male
Adult
Young Adult
Graft vs Host Disease
Child
Treatment Outcome
Prospective Studies

Source PubMed

Download CSV of topics

Trials1

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's record
NCT01850108Non-Myeloablative Conditioning and Bone Marrow TransplantationDerived from the trialYes

Source ClinicalTrials.gov

Download CSV of trials

References26

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114985486Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.N Engl J Med2004https://conductscience.org/library/papers/14985486PubMed
226348889Nonmyeloablative Stem Cell Transplantation with Alemtuzumab/Low-Dose Irradiation to Cure and Improve the Quality of Life of Adults with Sickle Cell Disease.Biol Blood Marrow Transplant2016https://conductscience.org/library/papers/26348889PubMed
336385464Effects of Erythrocytapheresis Procedures on Delayed Bone Marrow Conversion in Sickle Cell Disease.Clin Hematol Int2022https://conductscience.org/library/papers/36385464PubMed
436044658Increased incidence of hematologic malignancies in SCD after HCT in adults with graft failure and mixed chimerism.Blood2022https://conductscience.org/library/papers/36044658PubMed
525696857Guidelines for quantifying iron overload.Hematology Am Soc Hematol Educ Program2014https://conductscience.org/library/papers/25696857PubMed
622967259High one year mortality in adults with sickle cell disease and end-stage renal disease.Br J Haematol2012https://conductscience.org/library/papers/22967259PubMed
728423290Sickle Cell Disease.N Engl J Med2017https://conductscience.org/library/papers/28423290PubMed
827965196Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation.Blood2017https://conductscience.org/library/papers/27965196PubMed
97993409Mortality in sickle cell disease. Life expectancy and risk factors for early death.N Engl J Med1994https://conductscience.org/library/papers/7993409PubMed
1033534948Non-myeloablative human leukocyte antigen-matched related donor transplantation in sickle cell disease: outcomes from three independent centres.Br J Haematol2021https://conductscience.org/library/papers/33534948PubMed
1139939433The 2023 EBMT report on hematopoietic cell transplantation and cellular therapies. Increased use of allogeneic HCT for myeloid malignancies and of CAR-T at the expense of autologous HCT.Bone Marrow Transplant2025https://conductscience.org/library/papers/39939433PubMed
1225058217Nonmyeloablative HLA-matched sibling allogeneic hematopoietic stem cell transplantation for severe sickle cell phenotype.JAMA2014https://conductscience.org/library/papers/25058217PubMed
1326261241Low forced expiratory volume is associated with earlier death in sickle cell anemia.Blood2015https://conductscience.org/library/papers/26261241PubMed
1430913039Post-transplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression.J Clin Invest2019https://conductscience.org/library/papers/30913039PubMed
1531495699Effect of donor type and conditioning regimen intensity on allogeneic transplantation outcomes in patients with sickle cell disease: a retrospective multicentre, cohort study.Lancet Haematol2019https://conductscience.org/library/papers/31495699PubMed
1631782875Early viral reactivation despite excellent immune reconstitution following haploidentical Bone marrow transplant with post-transplant cytoxan for sickle cell disease.Transpl Infect Dis2020https://conductscience.org/library/papers/31782875PubMed
1738817956Risks and benefits of cannabis as a pain control modality in patients with sickle cell disease.Clin Hematol Int2023https://conductscience.org/library/papers/38817956PubMed
1833941871Successful mismatched hematopoietic stem cell transplantation for pediatric hemoglobinopathy by using ATG and post-transplant cyclophosphamide.Bone Marrow Transplant2021https://conductscience.org/library/papers/33941871PubMed
1938493482An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell disease.Blood2024https://conductscience.org/library/papers/38493482PubMed
2029981283Clustering of end-organ disease and earlier mortality in adults with sickle cell disease: A retrospective-prospective cohort study.Am J Hematol2018https://conductscience.org/library/papers/29981283PubMed

See all 26 referencesDownload CSV of references

Drugs5

The drugs whose trials, in the Pipelines release, list the paper.

DrugChEMBL IDThe trials list it asTrialsIn Drugs and targetsSource
CYCLOPHOSPHAMIDECHEMBL1200796Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1200796ChEMBL
MYCOPHENOLATE MOFETILCHEMBL1456Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1456ChEMBL
FLUDARABINECHEMBL1568Derived from the trial1https://conductscience.org/library/drugs/CHEMBL1568ChEMBL
SIROLIMUSCHEMBL413Derived from the trial1https://conductscience.org/library/drugs/CHEMBL413ChEMBL
MESNACHEMBL975Derived from the trial1https://conductscience.org/library/drugs/CHEMBL975ChEMBL

Download CSV of drugs

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • Cited by
  • Genes
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42049986

GET https://conductscience.org/api/papers/v1/42049986/references?page=2